University of California San Francisco | About UCSF | UCSF Benioff Children's Hospital San Francisco
Search Site | Find a Doctor

Sue Yom, M.D., Ph.D.

Radiation cancer specialist

Dr. Sue Yom is an expert in the radiation treatment and management of head, neck and lung cancers. In her research, she studies chemoradiation for these cancers as well as image-guided radiation therapy and ways to reduce toxicities using focused radiation techniques, emerging biological agents and radiation protectants.

Yom earned a medical degree and Ph.D. at the University of Pennsylvania and completed a residency in radiation oncology at the M.D. Anderson Cancer Center in Houston, Texas. She has received numerous awards recognizing her commitment to patient care and patient-oriented research.


Melanoma Center
1600 Divisadero St.,
San Francisco, CA 94115
Phone: (415) 353-9900
Fax: (415) 885-3802

Hours: Monday to Friday
8 a.m. – 5 p.m.

Radiation Oncology at Mount Zion
1600 Divisadero St., Basement Level
San Francisco, CA 94143-1708
Main Phone: (415) 353-7175
New Patient Appointments: (415) 353-9807
Fax: (415) 353-9884

Hours: Monday to Friday
7 a.m. – 6 p.m.

Radiation Oncology at Parnassus
505 Parnassus Ave, Room L-75
San Francisco, CA 94143-0226
Main Phone: (415) 353-7175
New Patient Appointments: (415) 353-8335
Fax: (415) 353-7281

Hours: Monday to Friday
8 a.m. – 4:30 p.m.

Conditions & Treatments

More about Sue Yom


University of Pennsylvania School of Medicine 2002


University of Texas Anderson Cancer Center, Radiation Oncology 2007

Selected Research and Publications

  1. Okoye CC, Jablons DM, Jahan TM, Kukreja J, Cardozo S, Yom SS. Divergent management strategies for typical versus atypical carcinoid tumors of the thoracic cavity. Am J Clin Oncol. 2014 Aug; 37(4):350-5.
  2. Yom SS, Cohen E. The ACR appropriateness criteria® for thyroid carcinoma: Searching for consensus in a rapidly evolving area. Oral Oncol. 2014 Jun; 50(6):575-6.
  3. Salama JK, Golden DW, Yom SS, Garg MK, Lawson J, McDonald MW, Quon H, Ridge JA, Saba N, Smith RV, Worden F, Yeung AR, Beitler JJ. ACR Appropriateness Criteria® thyroid carcinoma. Oral Oncol. 2014 Jun; 50(6):577-86.
  4. Yom SS. Q&A with dr jay s. Cooper about radiation therapy oncology group 9003. Int J Radiat Oncol Biol Phys. 2014 May 1; 89(1):10-2.
  5. Yu J, Aldabagh B, Wang J, Yom SS, El-Sayed I, Knott D, McGrath MH, Arron S. Multidisciplinary management of advanced Basal cell carcinoma: report of four cases. J Drugs Dermatol. 2014 May 1; 13(5):601-6.
  6. Ouyang D, El-Sayed IH, Yom SS. National trends in surgery for sinonasal malignancy and the effect of hospital volume on short-term outcomes. Laryngoscope. 2014 Jul; 124(7):1609-14.
  7. George JR, Yom SS, Wang SJ. Improved outcomes in adjuvant radiotherapy for oral cavity carcinoma at an academic center: A matched-pair analysis. Laryngoscope. 2014 Jul; 124(7):1603-8.
  8. Chainani-Wu N, Chang C, Gross AJ, Yom SS, Silverman S. Oropharyngeal carcinoma arising after methotrexate and etanercept therapy for rheumatoid arthritis. Oral Surg Oral Med Oral Pathol Oral Radiol. 2014 Mar; 117(3):e261-3.
  9. George JR, Yom SS, Wang SJ. Modality Treatment Outcomes for Head and Neck Cancer: Comparison of Postoperative Radiation Therapy at Academic vs Nonacademic Medical Centers. JAMA Otolaryngol Head Neck Surg. 2013 Nov 1; 139(11):1118-26.
  10. Ridge JA, Lawson J, Yom SS, Garg MK, McDonald MW, Quon H, Saba N, Salama JK, Smith RV, Worden F, Yeung AR, Beitler JJ. American college of radiology appropriateness criteria(®) treatment of stage I T1 glottic cancer. Head Neck. 2014 Jan; 36(1):3-8.
  11. Pfister DG, Ang KK, Brizel DM, Burtness BA, Busse PM, Caudell JJ, Cmelak AJ, Colevas AD, Dunphy F, Eisele DW, Gilbert J, Gillison ML, Haddad RI, Haughey BH, Hicks WL, Hitchcock YJ, Kies MS, Lydiatt WM, Maghami E, Martins R, McCaffrey T, Mittal BB, Pinto HA, Ridge JA, Samant S, Schuller DE, Shah JP, Spencer S, Weber RS, Wolf GT, Worden F, Yom SS, McMillian NR, Hughes M. Head and neck cancers, version 2.2013. Featured updates to the NCCN guidelines. J Natl Compr Canc Netw. 2013 Aug; 11(8):917-23.
  12. Garg MK, Ridge JA, Yom SS, McDonald MW, Quon H, Smith RV, Yeung AR, Lawson J, Saba N, Salama JK, Beitler JJ. Reply, contralateral irradiation for T(limited)N2bM0 lateralized tonsil cancer. Head Neck. 2013 Mar; 35(3):465-6.
  13. Dasgupta T, Haas-Kogan DA, Yang X, Olow A, Yang DX, Gragg A, Orloff LA, Yom SS. Genotype-dependent cooperation of ionizing radiation with BRAF inhibition in BRAF V600E-mutated carcinomas. Invest New Drugs. 2013 Oct; 31(5):1136-41.
  14. Yom SS. Oncology scan-head and neck cancers. Int J Radiat Oncol Biol Phys. 2013 Jan 1; 85(1):3-5.
  15. Pejavar S, Yom SS, Hwang A, Speight J, Gottschalk A, Hsu IC, Roach M, Xia P. Computer-assisted, atlas-based segmentation for target volume delineation in whole pelvic IMRT for prostate cancer. Technol Cancer Res Treat. 2013 Jun; 12(3):199-206.
  16. Saba NF, Yom SS, Haigentz M, El-Rayes B. Monoclonal Antibodies against Epidermal Growth Factor Receptor in Solid Tumors. Chemother Res Pract. 2012; 2012:291421.
  17. Graff P, Kirby N, Weinberg V, Chen J, Yom SS, Lambert L, Pouliot J. The residual setup errors of different IGRT alignment procedures for head and neck IMRT and the resulting dosimetric impact. Int J Radiat Oncol Biol Phys. 2013 May 1; 86(1):170-6.
  18. Kono SA, Haigentz M, Yom SS, Saba N. EGFR Monoclonal Antibodies in the Treatment of Squamous Cell Carcinoma of the Head and Neck: A View beyond Cetuximab. Chemother Res Pract. 2012; 2012:901320.
  19. Cooper JS, Zhang Q, Pajak TF, Forastiere AA, Jacobs J, Saxman SB, Kish JA, Kim HE, Cmelak AJ, Rotman M, Lustig R, Ensley JF, Thorstad W, Schultz CJ, Yom SS, Ang KK. Long-term follow-up of the RTOG 9501/intergroup phase III trial: postoperative concurrent radiation therapy and chemotherapy in high-risk squamous cell carcinoma of the head and neck. Int J Radiat Oncol Biol Phys. 2012 Dec 1; 84(5):1198-205.
  20. Yom SS, Chen CP, Jahan TM, Jablons DM. One size does not fit all lung cancer patients. J Thorac Oncol. 2012 May; 7(5):945.

Publications are derived from MEDLINE/PubMed and provided by UCSF Profiles, a service of the Clinical & Translational Science Institute (CTSI) at UCSF. Researchers can make corrections and additions to their publications by logging on to UCSF Profiles.